Clarity shares surge after $203m raising
Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company’s swift $203 million raising.
Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company’s swift $203 million raising.
The ASX has inched up on Monday as Trump cooled his tariff tantrum. Coal stocks took a hit from a Hunter Valley court ruling.
Melbourne-based Cygnet Capital backs opportunities in the critical minerals space, including the potential in Heavy Rare Earths.
Asian Battery Metals believes it may have made a significant copper-nickel-platinum group element discovery at its Oval project in Mongolia.
As China and the European Union engage in their 25th high-level summit in Beijing late this week, a delicate dance is unfolding.
Reventon says savvy young Aussies are choosing investment properties first – and it’s reshaping the housing market.
West Coast Silver will use funds from an oversubscribed $6.125m placement to accelerate exploration at its Elizabeth Hill project in WA’s Pilbara.
RC drilling is complete at Igrejinha’s key lithium targets with early insights on potential mineralisation to follow analysis of drill hole data.
Promising new research shows Alterity’s novel brain imaging tool could play a key role in diagnosing and tracking Multiple System Atrophy.
PLN’s Warmbad uranium exploration target is based on 31.7km of historical drilling and is open in multiple directions.
The pace of the quarterly reporting is picking up, with several up-and-coming biotechs revealing record performances.
Bitcoin is now part of mainstream allocation thinking and the expected $125,000 mark isn’t a finish line.
Hillgrove Resources is looking to grow its mining inventory at the Kanmantoo project in South Australia.
RLF AgTech reports a strong end to FY25 with customer cash receipts up 254% on previous quarter to $8.9 million for the June quarter.
Original URL: https://www.themercury.com.au/business/stockhead/page/9